iTeos
is a clinical-stage biotechnology company that researches and develops immunotherapies for the treatment of cancer... Read moreiTeos
is a clinical-stage biotechnology company that researches and develops immunotherapies for the treatment of cancer... Read more
2011
PublicAcquisition Pending from Concentra Biosciences, LLCNASDAQITOS
News
Aug 20, 2025
Benzinga
iTeos: ITEOS THERAPEUTICS INVESTOR ALERT BY THE FORMER ATTORNEY GENERAL OF LOUISIANA: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of iTeos Therapeutics, Inc. - ITOS
Aug 06, 2025
Benzinga
iTeos: ITeos Therapeutics Q2 EPS $(1.81) Misses $(0....
Jul 22, 2025
Owler
Iteos Therapeutics, Inc.: iTeos's revenue had no change from Dec 2024 to Mar 2025
Jul 21, 2025
FierceBiotechIT
iTeos: <a href="https://www.fiercebiotech.com/biotech/iteos-reeling-tigt-fail-becomes-latest-prize-deal-hungry-concentra" hreflang="en">iTeos, reeling from TIGIT fail, becomes latest prize for deal-hungry Concentra</a>
May 29, 2025
Pharamceutical Technology
iTeos: iTeos to shut down following $2bn GSK-partnered TIGIT asset failure
May 28, 2025
Investing.com
iTeos: iTeos Therapeutics stock surges on wind-down news By Investing.com
May 28, 2025
BioPharma Dive
iTeos: Cancer drugmaker iTeos to shut down
May 17, 2025
Americanbankingnews
iTeos: Research Analysts Issue Forecasts for ITOS Q2 Earnings
May 14, 2025
BioSpace
iTeos: GSK, iTeos Abandon TIGIT Therapy, Adding to Long List of Recent Failures
May 13, 2025
GlobeNewswire
Press Release: iTeos : iTeos Reports Topline Interim Results from GALAXIES Lung-201 Study of Belrestotug + Dostarlimab in First-Line, PD-L1 High Non-Small Cell Lung Cancer Patients
iTeos Competitors
1
2
3
4
5
6
7
8
9
10